{"SPADE_UN_28956": {"Sequence Information": {"Peptide Name": "MUC7 12-mer", "Sequence": "RKSYKCLHKRCR", "Sequence Length": 12, "Biological Activity": ["Anti-Gram+", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q8TAX7", "uniprotUrl": "http://www.uniprot.org/uniprot/Q8TAX7", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Antimicrobial and DNA-binding activities of the peptide fragments of human lactoferrin and histatin 5 against Streptococcus mutans.", "Pubmed ID": "21382611", "Reference": "Arch Oral Biol. 2011;56:869-876", "Author": "Huo L, Zhang K, Ling J, Peng Z, Huang X, Liu H, Gu L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21382611"}, {"Title": "Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide.", "Pubmed ID": "17996119", "Reference": "Ann Clin Microbiol Antimicrob. 2007;6:14", "Author": "Wei GX, Campagna AN, Bobek LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/17996119"}, {"Title": "Bactericidal synergy of lysostaphin in combination with antimicrobial peptides", "Pubmed ID": "21311938", "Reference": "Eur J Clin Microbiol Infect Dis. 2011;30:1015-1021", "Author": "Desbois AP, Coote PJ", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/21311938"}, {"Title": "In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.", "Pubmed ID": "15073161", "Reference": "J Antimicrob Chemother. 2004;53:750-758", "Author": "Wei GX, Bobek LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/15073161"}], "Mass": 1577.92, "PI": 10.47, "Net Charge": 7, "Hydrophobicity": -1.81, "Frequent Amino Acids": "KRC", "Absent Amino Acids": "ADEFGIMNOPQTUVW", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 9, "Positive Residues": 7, "Negative Residues": 0, "SPADE ID": "SPADE_UN_28956", "Similar Sequences": [{"SPADE_ID": "SPADE_N_03145", "Similarity": 1.0, "Sequence": "LAHQKPFIRKSYKCLHKRCR"}, {"SPADE_ID": "SPADE_N_05757", "Similarity": 1.0, "Sequence": "EGRERDHELRHRRHHHQSPKSHFELPHYPGLLAHQKPFIRKSYKCLHKRCR"}, {"SPADE_ID": "SPADE_N_05759", "Similarity": 1.0, "Sequence": "SPKSHFELPHYPGLLAHQKPFIRKSYKCLHKRCR"}], "Hemolytic Activity": "Horse erythrocytes:0% Hemolysis=128 µg/ml,Sheep erythrocytes:0% Hemolysis=128 µg/ml", "Target Organism": "Streptococcus mutans UA159(MIC=30.42±11.11µM),Streptococcus mutans GS-5(MIC=37.18±8.28µM),Streptococcus gordonii ATCC 10558(MIC=54.08±20.95µM),Streptococcus sanguinis ATCC 49295(MIC=74.36±16.56µM),Candida albicans(MIC=50µM),Candida albicans(90-100% Killing=25µM),Candida albicans(20-30% Killing=25µM),Candida albicans(10-20% Killing=25µM),Candida albicans(90-100% Killing=25µM),Candida albicans(40-50% Killing=25µM),Candida albicans(50-60% Killing=5µM),Candida albicans(0-10% Killing=5µM),Candida albicans(90-100% Killing=5µM),Candida albicans(MIC50=11µM),Candida albicans(MIC50=9µM),Candida albicans(MIC50=17.5µM),Candida albicans ATCC 96112(MIC=6.25µg/ml),Candida albicans(MIC=6.25µg/ml),Candida glabrata ATCC 90030(MIC=25.0µg/ml),Candida glabrata 65C(MIC=6.25µg/ml),Cryptococcus neoformans CN2(MIC=3.13µg/ml),Cryptococcus neoformans ATCC 52817(MIC=6.25µg/ml),Saccharomyces cerevisiae S288C(MIC=6.25µg/ml)"}}}